GSK said on Friday the European Medicines Agency had accepted the drugmaker's application to expand the use of its ...

This Original Lifetime Movie, "Pretty Hurts," airs June 28, at 8 p.m.

GSK is putting the finishing touches on its case for antibody-drug conjugate Blenrep with a key progression-free survival ...

The global IPV vaccines market is estimated to be valued at USD 199.9 Mn in 2025 and expected to reach at USD 358.5 Mn by 2032 With a CAGR of 8.7% during the forecast period (2025-2032). Coherent ...

GSK said it licensed its Shigella vaccine candidate, altaltSonflex1-2-3, to Bharat Biotech International.

Dozens of states are suing to block 23andMe's sale of personal genetic data, citing concerns over customer consent and ...

Several vaccine maker stocks slipped in after-hours trading Monday after Health Secretary Robert F. Kennedy Jr. announced a ...

The University of Waterloo’s School of Pharmacy announced Friday a partnership with multinational biopharma company ...

GlaxoSmithKline purchased Corixa, a biotech company with offices in South San Francisco, Seattle and Hamilton, for about $300 million. No details were available over the weekend about potential ...

The 12-year-old company had been collaborating with British pharmaceutical giant GlaxoSmithKline on an immuno-oncology drug ...

These mutated diseases defy the power of antibiotics. Are illnesses really mutating so fast that we can’t stay ahead of them?

With that, Theravance expects its lifetime value from the inhaler to come out to $1.52 billion. The drug stems from a 2002 ...